Anzeige
Mehr »
Samstag, 06.09.2025 - Börsentäglich über 12.000 News
SuperBuzz x Prymatica: Ein Vertriebsdeal, der KI-Hype in B2B-Umsätze verwandeln könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40J6T | ISIN: US53578M1027 | Ticker-Symbol:
NASDAQ
05.09.25 | 21:58
8,760 US-Dollar
+4,04 % +0,340
Branche
Immobilien
Aktienmarkt
Sonstige
1-Jahres-Chart
LINKHOME HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
LINKHOME HOLDINGS INC 5-Tage-Chart

Aktueller Chart LINKHOME Aktie

Chart vergleichen mit:

Firmenname, WKN, ISIN oder Aktien-Kürzel

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%
Chart-Typ:
Zeitraum:
 
LINKHOME HOLDINGS INC-Investoren interessieren sich auch für diese Wertpapiere
XFRA PBN0: AUSSETZUNG/SUSPENSIONDAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILALTERITY THERAP.ADR/600...
► Artikel lesen
XFRA NEW INSTRUMENTS AVAILABLE ON 20.08.2025The following instruments on XETRA do have their first trading 20.08.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 20.08.2025 Aktien 1 US02155X2053 Alterity Therapeutics...
► Artikel lesen
ALTERITY THERAPEUTICS LIMITED: Appendix 4C - Q4 FY25 Quarterly Cash Flow ReportHighlights Granted U.S. FDA Fast Track Designation for ATH434 to treat Multiple System Atrophy (MSA)Reported positive topline data from open-label Phase 2 clinical trial of ATH434 in MSAPresented...
► Artikel lesen
SurgePays Accelerates Growth Across All Business Verticals; Reports Q2 2025 Results and Issues Revenue Guidance of $75M to $90M in 2025 and $225M to $240M in 2026BARTLETT, Tenn., Aug. 13, 2025 /PRNewswire/ -- SurgePays, Inc. (Nasdaq: SURG) ("SurgePays" or the "Company"), a wireless and point-of-sale technology company...
► Artikel lesen
SurgePays Reports First Quarter 2025 Financial ResultsAT&T Integration Complete; Nationwide Launch Positions Company for Most Aggressive Growth Phase to Date Company Ships Over 250,000 SIM Cards and Secures $6 Million...
► Artikel lesen
Pre-market Movers: OSR Holdings, SurgePays, Beeline Holdings, Humacyte, Tenon MedicalOTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.45 A.M. ET).In the Green OSR Holdings, Inc. (OSRH) is up over 173% at $4.37. SurgePays...
► Artikel lesen
Tenaya Therapeutics, Inc.: Tenaya Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business UpdateEnrollment Complete in Cohorts 1 and 2 of MyPEAK-1 Phase 1b/2 Trial of TN-201 for MYBPC3-associated HCM; Positive DSMB Safety Review Enables Enrollment of Expansion Cohorts Cohort 1 of RIDGE-1 Phase...
► Artikel lesen
Tenaya Therapeutics, Inc.: Tenaya Receives Positive Safety Reviews from Independent DSMBs to Advance Both TN-201 and TN-401 Gene Therapy Clinical Trials as DesignedEnrollment in Both Dose Cohorts of the MyPEAK-1 Phase 1b/2 Clinical Trial of TN-201 for Hypertrophic Cardiomyopathy (HCM) Complete; Follow-up Data from Cohort 1 and Initial Data from Cohort 2 Expected...
► Artikel lesen
Tenaya Therapeutics, Inc.: Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)SOUTH SAN FRANCISCO, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially...
► Artikel lesen